معرفی
Samantha Gelfand, MD is an Assistant Professor of Medicine at Harvard Medical School with clinical appointments at Dana-Farber Cancer Institute and Brigham and Women's Hospital. She is a dual board-certified nephrologist and palliative medicine physician specializing in kidney palliative care for patients with advanced kidney disease.
Her educational background includes:
- Bachelor of Arts in Romance Languages and Literatures from Harvard College
- Doctor of Medicine from Icahn School of Medicine at Mount Sinai with distinction in medical education
Dr. Gelfand's clinical and academic focus centers on symptom management, medical decision-making, and conservative kidney management as an alternative to dialysis for seriously ill patients. Her work integrates nephrology and palliative medicine to address complex needs in advanced kidney disease, emphasizing patient-centered goals and quality-of-life optimization. She actively researches active medical management of kidney failure without dialysis, developing frameworks for ethical decision-making and holistic symptom control in this vulnerable population.
She is a core member of the Adult Palliative Care program at Dana-Farber Cancer Institute, where she provides specialized clinical care and contributes to program development for patients with serious illness.
